XM does not provide services to residents of the United States of America.

Stock rout spreads beyond tech



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>LIVE MARKETS-Stock rout spreads beyond tech</title></head><body>

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com


STOCK ROUT SPREADS BEYOND TECH

The global equity sell-off looks set to extend into Europe on Thursday although the region may be spared the carnage in parts of Asia, where Japan's Nikkei .N225 tumbled as much as 3% and Hong Kong's Hang Seng .HSI slumped close to 2%.

Earnings this week from the likes of Alphabet and Tesla have not supported the market's sky-high tech valuations, sending not just mega-cap stocks but all of Wall Street sliding back to earth from near-record peaks.

Japan's exporter-heavy equity market was hit particularly hard by a reversal in the yen,which has rebounded to about 152 per dollar from a three-decade trough near 162 yen per dollar JPY=EBS around the start of this month.

The yen has regained its safe-haven appeal right when traders were bailing out of short yen positions, amid a barrage of suspected currency interventions by Tokyo and before crucial policy decisions by the Bank of Japan and Federal Reserve, both on July 31.

Meanwhile, ailing Chinese markets continue to take a beating. Beijing's latest surprise rate cut on Thursday only stoked worries about the economy, rather than shoring up sentiment.

The more muted performance of European stocks relative to Wall Street and Japan over the past couple months means there's less froth to come off the top, potentially leading to a shallower sell-off.

But there are plenty of risk events to brace for as earnings season gathers momentum. From drugmakers AstraZeneca AZN.L and Sanofi SASY.PA to Stellantis STLAM.MI and BAT BATS.L, a wide swath of industry giants report on Thursday.

Nestle NESN.S will be one to watch, particularly if you're a fan of KitKat or Smarties. The company may be set to hike prices again in the run-up to Halloween and Christmas, after ruling out changing recipes as a way to deal with soaring cocoa prices.

Hermes HRMS.PA merits attention as well, after earnings at LVMH LVMH.PA and Gucci-owner Kering PRTP.PA were battered by flagging Chinese demand.

Clues to the overall business environment around Europe will also be offered in surveys from France, Germany and the UK.

Key developments that could influence markets on Thursday:

-France business climate (July), Germany Ifo business climate (July), UK CBI business optimism (Q3)

-Earnings from AstraZeneca AZN.L, BAT BATS.L, Hermes HRMS.PA, Nestle NESN.S, Sanofi SASY.PA, Stellantis STLAM.MI


(Kevin Buckland)

*****


Magnificent Seven performance https://tmsnrt.rs/46j9n4G

China's repo and overnight benchmark rates https://tmsnrt.rs/3WkWG6c

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.